The type 2 diabetes drug metformin helped slow aging across multiple organs, including the brain, kidneys, and the skin, a ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...

Yavapai County will be part of the High Intensity Drug Trafficking Area program, which opens up federal resources to police ...

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

Obesity is a disease characterized by having excessive body fat, increasing a person’s risk for many serious health problems, ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

Weight loss drugs have gained attention as a tool to help combat obesity, but understanding how they work, who they’re for, ...

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be ...

Metformin is the main first-line drug used to treat type 2 diabetes, but a new study on monkeys suggests it could one day be ...

Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic—so ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.